bioAffinity Technologies (BIAFW) Financial Statements
Price: $2
Market Cap: $26.98M
Avg Volume: -
Market Cap: $26.98M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of bioAffinity Technologies.
Income Statement
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Revenue | $2.53M | $4.80K | $- | $- | $- |
Cost of Revenue | $1.99M | $-0.00B | $4.82K | $22.24K | $40.28K |
Gross Profit | $542.02K | $4.34K | $-4.82K | $-22.24K | $-40.28K |
Gross Profit Ratio | 21.40% | 90.28% | 0.00% | 0.00% | 0.00% |
Research and Development Expenses | $1.72M | $1.29M | $1.33M | $1.61M | $1.85M |
General and Administrative Expenses | $6.79M | $2.73M | $880.77K | $994.34K | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $6.79M | $2.73M | $880.77K | $994.34K | $1.20M |
Other Expenses | $-27.80K | $-1.87M | $724.93K | $-4.28M | $- |
Operating Expenses | $8.52M | $4.02M | $2.21M | $2.60M | $3.05M |
Cost and Expenses | $10.51M | $4.02M | $2.21M | $2.60M | $3.09M |
Interest Income | $122.13K | $46.71K | $-0.00B | $1.07K | $2.78K |
Interest Expense | $37.12K | $2.53M | $1.00M | $382.17K | $214.83K |
Depreciation and Amortization | $249.59K | $10.18K | $4.82K | $22.24K | $40.28K |
EBITDA | $-7.72M | $-5.82M | $-1.48M | $-6.86M | $-3.05M |
EBITDA Ratio | -304.98% | -121196.96% | 0.00% | 0.00% | 0.00% |
Operating Income | $-7.97M | $-4.01M | $-2.21M | $-2.60M | $-3.09M |
Operating Income Ratio | -314.84% | -83511.51% | 0.00% | 0.00% | 0.00% |
Total Other Income Expenses Net | $57.21K | $-4.14M | $-4.12M | $-4.66M | $-212.06K |
Income Before Tax | $-7.92M | $-8.15M | $-6.32M | $-7.27M | $-3.30M |
Income Before Tax Ratio | -312.58% | -169720.05% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | $20.99K | $2.46K | $1.95K | $2.75K | $3.20K |
Net Income | $-7.94M | $-8.15M | $-6.33M | $-7.27M | $-3.31M |
Net Income Ratio | -313.41% | -169771.25% | 0.00% | 0.00% | 0.00% |
EPS | $-0.91 | $-1.81 | $-0.86 | $-0.99 | $-0.45 |
EPS Diluted | $-0.91 | $-1.81 | $-0.86 | $-0.99 | $-0.45 |
Weighted Average Shares Outstanding | 8.75M | 4.50M | 7.38M | 7.38M | 7.38M |
Weighted Average Shares Outstanding Diluted | 8.75M | 4.50M | 7.38M | 7.38M | 7.38M |
SEC Filing | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $2.82M | $11.41M | $1.36M | $83.11K | $578.48K |
Short Term Investments | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $2.82M | $11.41M | $1.36M | $83.11K | $578.48K |
Net Receivables | $811.67K | $10.49K | $1.53K | $1.53K | $1.53K |
Inventory | $18.48K | $5.54K | $71.85K | $28.35K | $- |
Other Current Assets | $321.02K | $119.77K | $4.22K | $5.67K | $37.49K |
Total Current Assets | $3.97M | $11.96M | $1.44M | $118.66K | $617.51K |
Property Plant Equipment Net | $1.99M | $214.44K | $4.63K | $9.45K | $28.80K |
Goodwill | $1.40M | $- | $- | $- | $- |
Intangible Assets | $833.47K | $- | $- | $- | $- |
Goodwill and Intangible Assets | $2.24M | $- | $- | $- | $- |
Long Term Investments | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- |
Other Non-Current Assets | $16.06K | $6.00K | $10.44K | $17.50K | $12.50K |
Total Non-Current Assets | $4.25M | $220.44K | $15.07K | $26.95K | $41.30K |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $8.22M | $12.18M | $1.45M | $145.60K | $658.81K |
Account Payables | $604.79K | $345.04K | $230.41K | $191.39K | $103.42K |
Short Term Debt | $460.17K | $251.75K | $11.20M | $9.95M | $4.01M |
Tax Payables | $- | $- | $- | $- | $- |
Deferred Revenue | $33.06K | $- | $- | $- | $- |
Other Current Liabilities | $1.15M | $541.89K | $1.60M | $976.10K | $579.93K |
Total Current Liabilities | $2.25M | $1.14M | $13.04M | $11.12M | $4.69M |
Long Term Debt | $1.12M | $- | $160.18K | $53.47K | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $596.79K | $4.04M | $4.04M | $- |
Total Non-Current Liabilities | $1.12M | $596.79K | $4.20M | $4.10M | $- |
Other Liabilities | $- | $-596.79K | $--0.00B | $- | $- |
Total Liabilities | $3.37M | $1.14M | $17.24M | $15.22M | $4.69M |
Preferred Stock | $- | $12.18B | $4.04M | $4.04M | $4.04M |
Common Stock | $65.76K | $58.67K | $18.74K | $18.72K | $18.72K |
Retained Earnings | $-44.60M | $-36.67M | $-28.51M | $-22.19M | $-14.92M |
Accumulated Other Comprehensive Income Loss | $- | $- | $-4.04M | $-4.04M | $-18.72K |
Other Total Stockholders Equity | $49.39M | $-12.13B | $12.70M | $7.10M | $6.84M |
Total Stockholders Equity | $4.86M | $11.04M | $-15.79M | $-15.07M | $-4.04M |
Total Equity | $4.86M | $11.04M | $-15.79M | $-15.07M | $-4.04M |
Total Liabilities and Stockholders Equity | $8.22M | $12.18M | $1.45M | $145.60K | $658.81K |
Minority Interest | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $8.22M | $12.18M | $1.45M | $145.60K | $658.81K |
Total Investments | $- | $- | $- | $- | $- |
Total Debt | $1.58M | $251.75K | $11.36M | $10.01M | $4.01M |
Net Debt | $-1.24M | $-11.16M | $10.00M | $9.92M | $3.43M |
Cash Flow Statement
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Net Income | $-7.94M | $-8.15M | $-6.33M | $-7.27M | $-3.31M |
Depreciation and Amortization | $249.59K | $10.18K | $4.82K | $22.24K | $40.28K |
Deferred Income Tax | $-964.09K | $- | $3.84M | $- | $- |
Stock Based Compensation | $748.82K | $248.59K | $43.01K | $275.73K | $- |
Change in Working Capital | $900.79K | $114.20K | $632.82K | $482.62K | $322.01K |
Accounts Receivables | $311.37K | $-8.96K | $- | $- | $-0.00B |
Inventory | $-12.94K | $-5.54K | $- | $- | $- |
Accounts Payables | $-14.50K | $114.64K | $39.02K | $87.97K | $-39.82K |
Other Working Capital | $616.87K | $14.07K | $593.80K | $394.65K | $361.54K |
Other Non Cash Items | $964.09K | $3.71M | $-244.35K | $4.28M | $575.11K |
Net Cash Provided by Operating Activities | $-6.04M | $-4.07M | $-2.05M | $-2.21M | $-2.49M |
Investments in Property Plant and Equipment | $-22.90K | $-219.99K | $- | $-2.89K | $-11.40K |
Acquisitions Net | $-2.19M | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- |
Other Investing Activities | $-2.21M | $- | $- | $- | $- |
Net Cash Used for Investing Activities | $-2.21M | $-219.99K | $- | $-2.89K | $-11.40K |
Debt Repayment | $-344.98K | $-694.98K | $-3.51M | $-1.72M | $-2.33M |
Common Stock Issued | $- | $6.03M | $- | $- | $- |
Common Stock Repurchased | $- | $--0.00B | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- |
Other Financing Activities | $-344.98K | $9.01M | $6.83M | $3.43M | $- |
Net Cash Used Provided by Financing Activities | $-344.98K | $14.34M | $3.33M | $1.72M | $2.33M |
Effect of Forex Changes on Cash | $-0.00B | $- | $- | $- | $- |
Net Change in Cash | $-8.59M | $10.05M | $1.28M | $-495.38K | $-166.59K |
Cash at End of Period | $2.82M | $11.41M | $1.36M | $83.11K | $578.48K |
Cash at Beginning of Period | $11.41M | $1.36M | $83.11K | $578.48K | $745.08K |
Operating Cash Flow | $-6.04M | $-4.07M | $-2.05M | $-2.21M | $-2.49M |
Capital Expenditure | $-22.90K | $-219.99K | $- | $-2.89K | $-11.40K |
Free Cash Flow | $-6.06M | $-4.29M | $-2.05M | $-2.21M | $-2.50M |